Surplus Solutions Expands with Certified Genetool Acquisition
Deal News | Apr 07, 2025 | NMS Capital
Surplus Solutions LLC, a portfolio company of NMS Capital, has announced its acquisition of Certified Genetool, a San Francisco-based provider of laboratory instruments and technical services. The move aims to enhance Surplus Solutions' service offerings and bolster its presence in the biotechnology, pharmaceutical, and life sciences sectors. Certified Genetool, which specializes in refurbished laboratory instruments, brings complementary capabilities including expertise in flow cytometry equipment, equipment certification, and service repairs. The acquisition is part of Surplus Solutions' strategy to develop a comprehensive equipment lifecycle management platform. Joe Reale, CEO of Surplus Solutions, highlighted the value of Certified Genetool's customer base and technical expertise. Brian Qian, CEO of Certified Genetool, expressed enthusiasm for the enhanced reach and service capability post-acquisition. NMS Capital's David Peterson noted the acquisition aligns with their focus on value-driven growth. McDermott Will & Emery served as legal advisors for Surplus Solutions, with financing from TPG Twin Brook Capital Partners. Certified Genetool received advice from Perkins Coie LLP.
Sectors
- Biotechnology and Pharmaceutical Equipment
- Private Equity
Geography
- United States – The acquisition and companies involved - Surplus Solutions and Certified Genetool - are based in the United States, specifically in Rhode Island and San Francisco.
Industry
- Biotechnology and Pharmaceutical Equipment – Both Surplus Solutions and Certified Genetool operate in providing refurbished and certified laboratory equipment, crucial for biotech and pharmaceutical industries.
- Private Equity – The transaction involves NMS Capital, a private equity firm, playing a strategic role in the acquisition and growth of its portfolio company.
Financials
- Undisclosed – The financial terms of the acquisition were not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Surplus Solutions LLC | Acquirer | Company | A global leader in procurement, resale, and management of used and refurbished laboratory equipment. |
| Certified Genetool, Inc. | Target company | Company | Provider of new, certified, and refurbished lab equipment, serving the biotech and pharmaceutical industries. |
| NMS Capital | Private Equity Firm | Company | Private equity firm managing assets over $1.5 billion, involved in strategic growth through investments in the Business and Healthcare Services industries. |
| McDermott Will & Emery | Legal Advisor to Surplus Solutions | Company | Law firm providing legal advice for the acquisition. |
| TPG Twin Brook Capital Partners | Financing Provider | Company | Provided financing for Surplus Solutions' acquisition of Certified Genetool. |
| Perkins Coie LLP | Legal Advisor to Certified Genetool | Company | Provided legal advice to Certified Genetool during the transaction. |
| Joe Reale | CEO of Surplus Solutions | Person | CEO leading Surplus Solutions' strategic growth and acquisition activities. |
| Dr. Brian Qian | CEO and Founder | Person | CEO and founder of Certified Genetool, steering the company's growth and integration post-acquisition. |
| David Peterson | Partner at NMS | Person | Partner at NMS Capital, involved in strategic decision-making for NMS's investments. |